Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1944
result was found. Results that relate to
R
Cost-effectiveness analysis of enzalutamide in the treatment of metastatic prostate cancer
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):269-276.
7226 times
1726 times
YANG Lei
WANG Fengling
HUANG Ling
LI Yan
ZHENG Hanrui
ZHENG Lingli
CHEN Li
Enzalutamide
Metastatic p
r
ostate cance
r
Ma
r
kov model
Cost-effectiveness analysis
Details
Pharmacoeconomic study of Bailing capsules plus conventional therapy in treating diabetic kidney disease
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):277-290.
7093 times
1441 times
HE Yumei
LI Wei
ZHU He
HAN Sheng
Bailing capsules
Diabetic kidney disease
Meta-analysis
Cost- effectiveness analysis
Pha
r
macoeconomics
Details
Efficacy and safety of Chinese patent medicine in the treatment of benign prostatic hyperplasia: a Bayesian network Meta-analysis
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):301-318.
9729 times
2488 times
MA Jia
XING Jianyue
ZHANG Yupeng
LIU Guangzhen
Chinese patent medicine
Benign p
r
ostate hype
r
plasia
Bayesian netwo
r
k Meta-analysis
R
andomized cont
r
olled t
r
ial
Details
Effectiveness of oral probiotics for hepatectomised patients: a Meta- analysis
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):319-329.
6270 times
1416 times
GONG Caifang
Xiong Yongfu
ZHAO Junyu
YOU Chuan
P
r
obiotics
Hepatic
r
esection
Infection
Meta-analysis
Systematic
r
eview
R
andomized cont
r
olled t
r
ial
Details
Efficacy and safety of hydroxychloroquine in the treatment of obstetric antiphospholipid syndrome: a Meta-analysis
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):330-341.
6936 times
1710 times
ZHANG Xuepei
TANG Xiuneng
LI Na
LIAO Shasha
LIU Yunyuan
HE Guanlan
ZHANG Hongliang
Hyd
r
oxychlo
r
oquine
Obstet
r
ic antiphospholipid synd
r
ome
Live bi
r
th
r
ate
Meta-analysis
Details
Strategy analysis of a case of failure in the treatment of severe pneumonia with ceftazidime avibactam and aztreonam
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):342-348.
8782 times
2260 times
WANG Genzhu
WANG Xiaoying
[ZHDL
Ca
r
bapenem-
r
esistant Klebsiella pneumonia
Ceftazidime-avibactam
Azt
r
eonam
Colistin sulfate
Tigecycline
Anti infection the
r
apy
Clinical pha
r
macist
Details
Rapid progression of colitis caused by lenvatinib combined with tislelizumab for hepatocellular carcinoma treatment: a case study
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(3):349-354.
8249 times
2722 times
MA Jinyuan
WANG Bei
ZHU Quangang
WANG Zhengxin
TAO Yifeng
QIU Xiaoyan
Ty
r
osine kinase inhibito
r
Anti-PD-1
Immune-
r
elated adve
r
se
r
eactions
Immune-
r
elated colitis
Case
r
epo
r
t
Details
Analysis of the urrent status of residual aluminum ion in human albumin
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):376-381.
8819 times
1601 times
ZHAN Li
ZENG Hao
WANG Wenxi
XIE Yuyuan
Human albumin
Aluminum ion
R
esidue
Glass bottle
Atomic abso
r
ption method
Details
Determination of related substances in gluaric anhydride by HPLC
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):382-387.
8217 times
1640 times
LIU Min
LIAN Zhenxia
LIU Yanxin
WANG Fan
LI Xia
YANG Haixia
Gluta
r
ic anhyd
r
ide
Succinic acid
Adipic acid
R
elated substances
High pe
r
fo
r
mance liquid ch
r
omatog
r
aphy
Details
Barriers and suggestions of pharmacy services for patients with chronic diseases provided by community pharmacy from the perspective of licensed pharmacist
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):388-396.
8203 times
1839 times
HU Yuanhui
PEI Yuyao
YU Feng
KANG Zheng
ZHENG Yufen
Community pha
r
macy
Ch
r
onic disease
Pha
r
macy se
r
vice
Ba
r
r
ie
r
s
Suggestions
Licensed pha
r
macist
Details
Construction and implementation of the 3M2S management model of drug dispensing department in Grade A Class-Three hospital
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):397-406.
8683 times
1629 times
FAN Jiani
SU Kejian
LIN Houwen
Outpatient pha
r
macy
Total quality management
Dispensing depa
r
tment
Management model
G
r
ade-A te
r
tia
r
y hospital
Details
Survey on knowledge, attitudes and practices of safe medication of antibiotic among parents of preschool children: a cross-sectional study
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):407-414.
7556 times
1488 times
DAI Min
WANG Fengwei
DAI Nini
WANG Li
P
r
eschool child
r
en
Pa
r
ents
Antibiotics
Safe medication use
Knowledge and p
r
actice
Details
Evaluation of factors affecting intravenous immunoglobulin resistance and construction of IVIGR risk prediction model in children with Kawasaki disease
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):415-422.
7486 times
1907 times
ZHU Jiacong
ZHANG Xu
Kawasaki disease
Int
r
avenous immunoglobulin
r
esistance
R
isk p
r
ediction model
R
isk-st
r
atified nu
r
sing
R
eceive
r
ope
r
ating cha
r
acte
r
istic cu
r
ve
Influencing facto
r
s
Details
Effect assessment of She medicine-melastoma dodecandrum water extract fumigation combined with; imrecoxib table in cervical spondylotic radiculopathy
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):423-430.
7705 times
1698 times
ZHANG Xingyang
LIN Hongzheng
ZHOU Jian
She medicine-melastoma dodecand
r
um wate
r
Im
r
ecoxib tablet
Ce
r
vical spondylosis with
r
adiculopathy
Pain seve
r
ity
Quality of life
Details
Study on the application effect of metformin combined with information-motivation-behavioral model intervention in patients with type 2 diabetes
Published on
Frontiers in Pharmaceutical Sciences
2024,27(3):431-439.
7406 times
1672 times
YU Li
WANG Xiarong
ZHANG Huabei
WU Huan
YIN Qiong
HU Liuqing
ZHOU Hongyu
Type 2 diabetes
Metfo
r
min t
r
eatment
Info
r
mation-motivation-behavio
r
al model inte
r
vention
Satisfaction
Details
上一页
1
2
49
50
51
52
53
54
55
129
130
下一页